Use of Artemisinin for Treating Tumors Induced by oncogenic Viruses and for Treating Viral Infections
AssigneeGeorgetown University
InventorsRichard SCHLEGEL, Dan-Paul HARTMANN, Astrid BAEGE
Life of this patent
Estimating the term…
Abstract
In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infection by administering artemisinin-related compounds. In certain aspects, the invention relates to methods of treating a tumor induced by an oncogenic virus, methods of killing or inhibiting a squamous cell carcinoma, and methods of inhibiting the replication of a virus, by administering artemisinin-related compounds.
Claims9
1-54. (canceled)
A method of treating Human papillomavirus (HPV)-induced anal cancer in a human subject, the method comprising:
- identifying a subject with HPV-induced anal cancer, and
- administering a therapeutically effective amount of an artemisinin-related compound to the identified subject, wherein the artemisinin-related compound is artemisinin, dihydroartemisinin, artemether, arteether, artesunate, artelinic acid, dihydroartemisinin propyl carbonate, or any combination thereof, and
- wherein the artemisinin-related compound is administered to the identified human subject by oral administration, topical administration, parenteral administration, rectal administration, systemic administration, intramuscular administration, or intravenous administration.
The method of claim 63, wherein the artemisinin-related compound is artemisinin.
The method of claim 63, wherein the artemisinin-related compound is artesunate.
The method of claim 63, wherein the artemisinin-related compound is formulated with a pharmaceutically acceptable carrier.
The method of claim 63, wherein the artemisinin-related compound is administered with an anti-viral agent.
The method of claim 67, wherein the artemisinin-related compound and the anti-viral agent are in the same formulation.
The method of claim 63, wherein the artemisinin-related compound is administered with an anti-cancer agent.
The method of claim 69, wherein the artemisinin-related compound and the anti-cancer agent are in the same formulation.
Dependencies are inferred from the claim text.